Ayurvedic Herbology and Autism Spectrum Disorder : A Comprehensive Study on Traditional Knowledge, Herbal Pharmacology, and Emerging Clinical Evidence

Authors

  • Dr. Navdeep Sharma Department of Psychology, Sikkim Sardar Patel University; Jorethang Road, Namchi, South Sikkim, India Author

Keywords:

Social Behaviour, Traditional Ayurvedic Practices, Pharmacology, Herb-Drug Interactions

Abstract

Autism Spectrum Disorder (ASD) is a multifactorial neurodevelopmental condition characterised by deficits in social communication, restricted behaviours, and frequent co-occurring disturbances such as anxiety, gastrointestinal dysfunction, sleep problems, and immune dysregulation (Lord et al., 2020; Lai et al., 2019). Conventional treatment approaches—including behavioural interventions, educational strategies, and pharmacological management—have improved outcomes but remain limited in addressing core deficits and often carry side effects (Hyman et al., 2020; Zwaigenbaum et al., 2015). This has generated interest in complementary and integrative medicine, particularly Ayurveda, which offers a centuries-old pharmacopeia of botanicals with neuroprotective, adaptogenic, and cognition-enhancing potential (Chaudhary & Singh, 2018). Herbs such as Bacopa monnieri (Brahmi), Withania somnifera (Ashwagandha), Centella asiatica (Gotu kola), and curcumin from Curcuma longa are traditionally used for memory enhancement, stress regulation, and systemic balance, and contemporary pharmacological research demonstrates their roles in modulating oxidative stress, neuroinflammation, mitochondrial dysfunction, and neurotransmitter activity (Stough et al., 2013; Singh et al., 2011; Devkota et al., 2020; Gupta et al., 2021). Emerging clinical and preclinical studies suggest potential behavioural and cognitive benefits in ASD, including improvements in attention, reduction in irritability, and enhanced adaptive functioning, though findings remain preliminary and methodologically heterogeneous (Agarwal et al., 2021; Hurwitz et al., 2021). A key limitation is the lack of large-scale, standardised clinical trials assessing safety, dosage, and herb–drug interactions, which constrains integration into evidence-based practice. This study synthesises traditional Ayurvedic perspectives, mechanistic pharmacology, and current evidence to provide a comprehensive understanding of the relevance of Ayurvedic herbology in ASD. It further highlights research gaps and proposes directions for rigorous, interdisciplinary exploration that may pave the way for safe and effective integrative frameworks in autism care.

Downloads

Download data is not yet available.

References

Agarwal, R., Donnelly, C., & Wang, C. (2021). Complementary and alternative medicine use in autism spectrum disorder: A systematic review. Pediatrics, 148(6), e2021052907.

Chaudhary, A., & Singh, N. (2018). Ayurvedic medicinal plants as cognitive enhancers: Evidence and future perspectives. Ancient Science of Life, 37(3), 123–129.

Devkota, H. P., Sharma, K., Joshi, R., & Basnet, P. (2020). Centella asiatica (Gotu kola): An ethnopharmacological and phytopharmacological review. Frontiers in Pharmacology, 11, 568859.

Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2621). Curcumin: The Indian solid gold for neuroprotective applications. Neurochemistry International, 146, 105094.

Hyman, S. L., Levy, S. E., & Myers, S. M. (2020). Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics, 145(1), e20193447.

Kumar, H., Kim, I. S., More, S. V., Kim, B. W., & Choi, D. K. (2022). Natural products for the treatment of neuroinflammation in neurological disorders. Phytotherapy Research, 36(2), 555–573.

Lord, C., Elsabbagh, M., Baird, G., & Veenstra-Vanderweele, J. (2020). Autism spectrum disorder. The Lancet, 395(10242), 508–520.

Singh, N., Bhalla, M., de Jager, P., & Gilca, M. (2011). An overview on Ashwagandha: A Rasayana (rejuvenator) of Ayurveda. African Journal of Traditional, Complementary and Alternative Medicines, 8(5 Suppl), 208–213.

Stough, C., Pase, M., Cropley, V., Myers, S., Nolidin, K., Wesnes, K., … Scholey, A. (2013). A randomized controlled trial investigating the effects of Bacopa monnieri (Brahmi) on cognition in healthy older Australians. Neuropsychopharmacology, 38(13), 2294–2302.

Downloads

Published

20-09-2025

Issue

Section

Research Articles

How to Cite

[1]
Dr. Navdeep Sharma, “Ayurvedic Herbology and Autism Spectrum Disorder : A Comprehensive Study on Traditional Knowledge, Herbal Pharmacology, and Emerging Clinical Evidence”, Int J Sci Res Humanities and Social Sciences, vol. 2, no. 5, pp. 61–68, Sep. 2025, Accessed: Dec. 13, 2025. [Online]. Available: https://mail.ijsrhss.com/index.php/home/article/view/IJSRHSS252527